Navigation Links
HIV/AIDS linked to extensively drug resistant TB

uences of the problem in greater detail, Friedland said, with operational research focused on quickly determining what kind of infection control practices can practically and feasibly be instituted to reduce the transmission of this lethal form of tuberculosis to others.

Friedland said there is a desperate need for new diagnostic tests and treatment for TB. "It is still being diagnosed the same way it was in 1882," he said. "Modern technology for diagnosis and new treatment needs to be developed urgently. The last approved TB drug was 40 years ago."
'"/>

Source:Yale University


Page: 1 2

Related biology news :

1. New therapy for HIV/AIDS eliminates needles and excessive toxicity
2. South Africa still debating how to tackle HIV/AIDS when 5 million are infected
3. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
4. Progress on HIV/AIDS significant but insufficient
5. HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate
6. International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
7. Study defines effective microbicide design for HIV/AIDS prevention
8. Rhesus monkeys in Nepal may provide new alternative for HIV/AIDS research
9. Cornell researcher helping develop quick, cheap HIV/AIDS test
10. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
11. Low level of extinction during ice age linked to adaptability
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HIV AIDS linked extensively drug resistant

(Date:11/6/2014)... 6, 2014 - Insilico Medicine, Inc, a Baltimore-based ... age related diseases announced a research collaboration with ... Champions Oncology, Inc (OTC: CSBR). , "There are ... medicine, but Champions Oncology,s TumorGraft technology is unique ... chemotherapy regimen experimentally generating vast amounts of valuable ...
(Date:11/5/2014)... de Janeiro, Brazil -Individuals show great diversity in their ... males and females greatly differ in their perceptual evaluation ... of smell tests. , Sex differences in ... behaviors and may be connected to one,s perception of ... emotions. Thus, women,s olfactory superiority has been suggested to ...
(Date:11/4/2014)... Temple University School of Medicine announced today that ... initiative funded by the Bill & Melinda Gates ... Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair ... School of Medicine will pursue an innovative global ... Biomarkers to Assess Fetal Neurodevelopment.", Grand Challenges Explorations ...
Breaking Biology News(10 mins):Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2The female nose always knows: Do women have more olfactory neurons? 2Temple University School of Medicine receives Grand Challenges Explorations grant 2
... have been identified as highly efficient generators of electricity. , ... high concentrations in the stratosphere orbiting the earth with the ... biofilm that has been engineered by a team of scientists ... from the Wear Estuary, Country Durham, UK, the team tested ...
... N.M Sandia National Laboratories researchers, using off-the-shelf ... on ways to improve amputees, control over prosthetics ... Organic materials chemist Shawn Dirk, robotics engineer Steve ... The goal is improved prosthetics with flexible nerve-to-nerve ...
... Researchers at The Pennsylvania State University College of ... integrity of the opioid growth factor receptor (OGFr), which ... on cell proliferation, is a key to understanding the ... of human ovarian cancer cells that were molecularly engineered ...
Cached Biology News:Superbugs from space offer new source of power 2Sandia seeks better neural control of prosthetics for amputees 2Sandia seeks better neural control of prosthetics for amputees 3Sandia seeks better neural control of prosthetics for amputees 4Sandia seeks better neural control of prosthetics for amputees 5A breakthrough in understanding the biology and treatment of ovarian cancer 2A breakthrough in understanding the biology and treatment of ovarian cancer 3
(Date:11/24/2014)... (PRWEB) November 24, 2014 The ... ” from METTLER TOLEDO demonstrates how to reduce ... Power analytics and sample panel design can be ... chemistry and protect against corrosion and deposition. Dedicated ... a significant amount of panel space. Additionally, installing ...
(Date:11/24/2014)... , November 24, 2014 Senior ... honored for dynamic leadership skills, business acumen ... and medical information products and services, congratulates Diane ... Clinical Reference and Workflow, Elsevier Clinical Solutions, for being ... Watching ® Awards issue of Profiles in ...
(Date:11/22/2014)... 21, 2014 Two new educational webinars hosted ... next for ALS research and how the pharmaceutical industry can ... Ice Bucket Challenge: Where Does the ALS Money Go? , ... December 2014, Time: 1:30pm ET, Register to attend ... Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology at Massachusetts ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 Prominent ... investors will gather on December 3rd at Genetic ... Conferences series. GeneticRx will take place at the ... School and will discuss the present and future ... exon skipping, and gene editing—as well as the ...
Breaking Biology Technology:New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... March 7, 2012   Spherix Incorporated (NASDAQ: ... biotechnology for therapy in diabetes, metabolic syndrome and ... services to food, supplement, biotechnology and pharmaceutical companies ... candidates, SPX-106T, arrested development and reduced atherosclerotic plaque ...
... than 1,100 leaders from across California,s life sciences industry ... CALBIO2012: Driven by Patients on March 8-9. The conference ... through partnering and collaborative research. For the ... meeting for California,s life sciences companies. CALBIO2012: Driven by ...
... March 7, 2012  Today, Cobalt Technologies , ... the achievement of major progress toward commercial scale ... in cooperation with ANDRITZ , a globally ... the pulp and paper industry, tested its dilute ...
Cached Biology Technology:SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease 2SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease 3SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease 4First Statewide Biotech Meeting Focuses on Patient Access, Innovation 2Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration 2Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration 3
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Agarose Gel Loading Dye Mixture 6X...
...
Biology Products: